Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.67 USD
Change Today -0.62 / -1.86%
Volume 394.4K
As of 6:40 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sue Bailey M.D., D.O.

Director, Member of Nominating & Corporate Governance Committee and Member of Scientific Review Committee,Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 3 different organizations across 3 different industries.

See Board Relationships
71$248,304

Background*

Dr. Sue Bailey, M.D., D.O. served as a News Analyst of NBC Universal from November 2001 to August 2006. Dr. Bailey served as an Administrator for the National Highway Traffic Safety Administration from 2000 to 2001, as Assistant Secretary of Defense (Health Affairs) from 1998 to 2000, and as Deputy Assistant Secretary Of Defense (Clinical Services) from 1994 to 1995. During her tenure with DoD Health Affairs, Dr. Bailey headed the $17 billion military medical system, ...

Read Full Background

Corporate Headquarters*

400 Professional Drive
Gaithersburg, Maryland 20879

United States

Phone: 240-631-3200
Fax: --

Board Members Memberships*

Trustee
2007-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Scientific Review Committee

Education*

Unknown/Other Education
George Washington University
BS
University of Maryland
MD
Philadelphia College Of Osteopathic Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$83,643
Total Calculated Compensation$248,304
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $32.67 USD -0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
$982.5K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$814.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.